Qkine is delighted to achieve ISO 9001:2015 recertification, an internationally recognized standard that confirms our commitment to exceptional product quality, customer service and scientific support
Qkine is pleased to announce that it has successfully been recertified with the international standard ISO 9001:2015 by the globally respected UKAS accredited BSI, giving enhanced confidence in the assessment of best practices. This standard shows our dedication to raising the standard of bioactive proteins through implementation of continual improvement, scientific innovation and exceptional scientific and customer support.
In 2021, Qkine committed to implementing an ISO 9001:2015 compliant quality management system encompassing its entire R&D, manufacturing, and operations functions. Embedding this internationally recognized standard demonstrated a commitment to consistently meet and exceed customer expectations and applicable statutory and regulatory requirements. This re-certification confirms the position of our quality management systems as the core of our company operations and science.
Ms Jennifer Jeffreys, Quality Manager, commented on the team’s achievement:
“Achieving this re-certification confirms our commitment to a consistently high standard of quality in all areas of Qkine and ensures that our customers, employees and stakeholders can be confident in our products and services. The team’s sustained dedication to continuous improvement and embedded quality principles has enhanced new product development and efficiency across our operations.”
Quality and reliability are essential to improve reproducibility in the growth factor and cytokine supply chain
Qkine manufactures essential protein reagents for the stem cell, organoid, regenerative medicine and cellular agriculture sectors at its Cambridge, UK facility. As a supplier to this intensely innovative industry, maintaining high product quality and standards of scientific support is often crucial to the success of the customer’s business processes and experimental outcomes.
Dr Catherine Elton, CEO, added:
“The positive feedback from the BSI auditor is testament to the sustained commitment of the company to embedding quality principles into everything we do. The recent development of the scientific quality systems to incorporate requirements for raw materials supply into pre-clinical applications and high quality food grade growth factors charts a forward looking path for continued development of the quality management system aligned with our company strategic ambitions.”
ISO 9001:2015 recertification gives continued confidence to global customers and confirms our commitment to raising standards of bioactive protein manufacturing and innovation
Qkine has implemented an ISO 9001:2015 compliant quality management system encompassing its entire R&D, manufacturing, and operations functions. In addition, we have adopted our Nine-point Quality Commitment to manufacturing bioactive proteins of the highest quality to enhance scientific outcomes and improve reproducibility.
